A high-resolution three-dimensional T1-weighted gradient echo sequence improves the detection of disease activity in multiple sclerosis

Annals of Neurology

Volumn 40, Issue 6, 1996, Pages 901-907

  Filippi, M ^a,d   Yousry, T ^b   Horsfield, M A ^c   Alkadhi, H ^b   Rovaris, M ^a   Campi, A ^a   Voltz, R ^b   Comi, G ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

^d SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM PENTETATE;

ADULT; ARTICLE; BRAIN SLICE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; HUMAN; IMAGE RECONSTRUCTION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RELAPSE; REMISSION; THREE DIMENSIONAL IMAGING;

ADULT; BRAIN; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MULTIPLE SCLEROSIS;

EID: 0030511762     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410400612     Document Type: Article

References (43)

1. Smith ME, Stone LA, Albert PS, et al. Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesions. Ann Neurol 1993;33:480-489
2. Khoury SJ, Guttmann CRG, Orav EJ, et al. Longitudinal MRI in multiple sclerosis: correlation between disability and lesion burden. Neurology 1994;44:2120-2124
3. Guttmann CRG, Ahn SS, Hsu L, et al. The evolution of multiple sclerosis lesions on serial MR. AJNR 1995;16:1481-1491
4. Stone LA, Smith ME, Albert PS, et al. Blood-brain barrier disruption on contrast-enhanced MRI in patients with mild relapsing-remitting multiple sclerosis: relationship to course, gender, and age. Neurology 1995;45:1122-1126
5. Hartung HP, Reiners K, Archelos JJ, et al. Circulating adhesion molecules and tumor necrosis factor receptor in multiple sclerosis: correlation with magnetic resonance imaging. Ann Neurol 1995;38:186-193
6. 2+ influx in patients with relapsing-remitting multiple sclerosis. Neurology 1996;46:1416-1421
7. Hawkins CP, Munro PMG, Mackenzie F, et al. Duration and selectivity of blood-brain barrier breakdown in chronic relapsing experimental allergic encephalomyelitis studied by gadolinium-DTPA and protein markers. Brain 1990;113:365-378
8. Katz D, Taubenberger JK, Cannella B, et al. Correlation between magnetic resonance imaging findings and lesion development in multiple sclerosis. Ann Neurol 1993;34:661-669
9. Miller DH, Barkhof F, Berry I, et al. Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines. J Neurol Neurosurg Psychiatry 1991; 54:683-688
10. Miller DH, Barkhof F, Nauta JJP. Gadolinium enhancement increased the sensitivity of MRI in detecting disease activity in MS. Brain 1993;116:1077-1094
11. Haustein J, Laniado M, Niendorf HP, et al. Triple-dose versus single-dose gadopentetate dimeglumine: a randomised study of 199 patients. Radiology 1993;186:855-860
12. Wolanski LJ, Bardini JA, Cook SD, et al. Triple-dose versus single-dose gadoteridol in multiple sclerosis patients. Neuroimag 1994;4:141-145
13. Filippi M, Campi A, Martinelli V, et al. Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with primary progressive multiple sclerosis. J Neurol Neurosurg Psychiatry 1995;59: 540-544
14. Filippi M, Yousry T, Campi A, et al. Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with multiple sclerosis. Neurology 1996;46:379-384
15. Filippi M, Capra R, Campi A, et al. Triple dose of gadolinium-DTPA and delayed scanning in benign multiple sclerosis. J Neurol Neurosurg Psychiatry 1996;60:526-530
16. Finelli DA, Hurst GC, Gullapali RP, Bellon EM. Improved contrast of enhancing brain lesions on post-gadolinium T1 weighted spin-echo images with use of magnetization transfer. Radiology 1994;36:62-67
17. Metha RC, Pike BG, Enzmann R. Improved detection of enhancing and non-enhancing lesions of multiple sclerosis with magnetization transfer. AJNR 1995;16:1771-1778
18. Filippi M, Yousry T, Rocca MA, et al. Sensitivity of delayed enhanced MRI in multiple sclerosis. Proc Int Soc Magn Reson Med 1996;1:543 (Abstract)
19. Lai M, Hodgson T, McDonald WI, Miller DH. Weekly vs monthly brain MRI for detection of disease activity in multiple sclerosis. J Neurol 1995;242(suppl 2):S6-S7 (Abstract)
20. Rydberg JN, Hammond CA, Grimm RC, et al. Initial experience in MR imaging of the brain with a fast fluid-attenuated inversion-recovery pulse sequence. Radiology 1994;193:173-180
21. Barbosa S, Blumhardt LD, Roberts N, et al. Magnetic resonance relaxation time mapping in multiple sclerosis: normal appearing white matter and the "invisible" lesion load. Magn Reson Imaging 1994;12:33-42
22. Filippi M, Campi A, Dousset V, et al. A magnetization transfer imaging study of normal-appearing white matter in multiple sclerosis. Neurology 1995;45:478-482
23. Filippi M, Horsfield MA, Campi A, et al. Resolution-dependent estimates of lesion volumes in magnetic resonance imaging studies of the brain in multiple sclerosis. Ann Neurol 1995;38:749-754
24. Loevner LA, Grossman RI, Cohen JA, et al. Microscopic disease in normal-appearing white matter on conventional MR images in patients with multiple sclerosis: assessment with magnetization-transfer measurements. Radiology 1995;96:511-515
25. Davies SEC, Newcombe J, Williams SR, et al. High resolution proton NMR spectroscopy of multiple sclerosis lesions. J Neurochem 1995;64:742-748
26. Roser W, Hagberg G, Mader I, et al. Proton MRS of gadolinium-enhancing MS plaques and metabolic changes in normal-appearing white matter. Magn Reson Med 1995;33:811-817
27. Filippi M, Yousry T, Baratti C, et al. Quantitative assessment of MRI lesion load in multiple sclerosis: a comparison of conventional spin-echo with fast-fluid-attenuated inversion recovery. Brain 1996 (In press)
28. Mugler JP, Brookeman JR. Three-dimensional magnetization-prepared rapid gradient-echo imaging (3D MP RAGE). Magn Reson Med 1990;15:152-157
29. 1-weighted gradient-echo sequence - initial experience in the brain. Radiology 1992;182:769-775
30. 1-weighted gradient echo MRI in multiple sclerosis patients. J Comput Tomogr 1992;16:731-736
31. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33:1444-1452
32. Henkeiman RM. Measurements of signal intensities in the presence of noise in MR images. Med Phys 1985;12:232-233
33. Van Buchem MA, Grossman RI, McGowan JC. Volumetric MTR analysis of disease burden in multiple sclerosis. Proc Soc Magn Reson 1995;1:281 (Abstract)
34. Brownell B, Hughes JT. The distribution of plaques in the cerebrum in multiple sclerosis with special reference to cerebral plaques. Acta Neurol Scand 1962;41:1-161
35. Lumdsen CE. The neuropathology of multiple sclerosis. In: Vinken PJ, Bruyn GW, eds. Handbook of clinical neurology, vol 9. Amsterdam: North Holland, 1970:217-309
36. Revesz T, Kidd D, Thompson AJ, et al. A comparison of pathology of primary and secondary progressive multiple sclerosis. Brain 1994;117:759-765
37. Berry I, Barker GJ, Barkhof F, et al. A multi-centre measurement of magnetisation transfer ratio in normal white matter. Proc Int Soc Magn Reson Med 1996;1:536 (Abstract)
38. Kermode AG, Tofts PS, Thompson AJ, et al. Heterogeneity of blood-brain barrier changes in multiple sclerosis: an MRI study with gadolinium-DTPA enhancement. Neurology 1990; 40:229-235
39. Tofts PS, Kermode AG. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. Fundamental concepts. Magn Reson Med 1991;17: 357-367
40. Miller DH, Albert PS, Barkhof F, et al. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. Ann Neurol 1996;39:6-16
41. McFarland HF, Frank JA, Albert PS, et al. Using gadolinium-enhanced magnetic resonance imaging to monitor disease activity in multiple sclerosis. Ann Neurol 1992;32:758-766
42. Nauta JJP, Thompson AJ, Barkhof F, Miller DH. Magnetic resonance imaging in monitoring the treatment of multiple sclerosis patients: statistical power of parallel-groups and crossover designs. J Neurol Sci 1994;122:6-14
43. Filippi M, Horsfield MA, Tofts PS, et al. Quantitative assessment of MRI in monitoring the evolution of multiple sclerosis. Brain 1995;118:1601-1612